A Phase II Tolerability Study of Cisplatin Plus Docetaxel as Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer

INTRODUCTION: We undertook this phase II study to measure postoperative drug delivery and toxicity of cisplatin plus docetaxel in patients with resected stage I-III non-small cell lung cancer. METHODS: The primary endpoint was amount of cisplatin delivered over a planned four cycles of adjuvant chem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Azzoli, Christopher G., Krug, Lee M., Miller, Vincent A., Rizvi, Naiyer A., Kris, Mark G., Dunne, Megan, Farmer, Amy, Pizzo, Barbara, Tyson, Leslie, Seeger, Teresa, Coleman, Barbara, Moore, Erin, Lastinger, Lauren, Venkatraman, Ennapadam, Rudin, Charles M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715043/
https://ncbi.nlm.nih.gov/pubmed/17607120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e318074bbd0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados